Table 2
Odds ratios for retinal vascular occlusive disease and increased total plasma homocysteine (tHcy) levels conferred by TT genotype
| TT | Odds ratio | 95% CI | |
| Cases (n=87) | 13 (14.9%) | 0.84 | 0.37 to 1.90 |
| Venous (n=61) | 8 (9.2%) | 0.72 | 0.29 to 1.83 |
| Arterial (n=26) | 5 (5.7%) | 1.14 | 0.37 to 3.51 |
| versus | |||
| Controls (n=87) | 15 (7.2%) | ||
| Cases with increased tHcy (n= 43) | 5 (11.6%) | 0.59 | 0.18 to 1.98 |
| versus | |||
| Cases with normal tHcy (n=44) | 8 (18.1%) | ||
| Controls with increased tHcy (n=22) | 2 (9.0%) | 0.40 | 0.04 to 2.04 |
| versus | |||
| Controls with normal tHcy (n=65) | 13 (20.0%) | ||
| All subjects with increased tHcy (n=65) | 7 (9.2%) | 0.51 | 0.20 to 1.26 |
| versus | |||
| All subjects with normal tHcy (n=109) | 21 (19.2%) |
-
↵TT = homozygous for thermolabile MTHFR genotype.
